Whitebox Advisors’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Whitebox Advisors’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.17K	Hold	42,293	–	–	﹤0.01%	551
2025 Q4	$2.12K	Hold	42,293	–	–	﹤0.01%	484
2025 Q3	$2.19K	Hold	42,293	–	–	﹤0.01%	421
2025 Q2	$2.01K	Hold	42,293	–	–	﹤0.01%	374
2025 Q1	$3.26K	Hold	42,293	–	–	﹤0.01%	293
2024 Q4	$3.89K	Sell	42,293 -3,183	-7%	-$271	﹤0.01%	242
2024 Q3	$2.92K	Hold	45,476	–	–	﹤0.01%	256
2024 Q2	$3.14K	Hold	45,476	–	–	﹤0.01%	267
2024 Q1	$3.02K	Hold	45,476	–	–	﹤0.01%	269
2023 Q4	$1.36K	Buy	+45,476	New	+$3.54K	﹤0.01%	272
2023 Q3	–	Sell	-45,476	Closed	-$2.52K	–	390
2023 Q2	$2.52K	Hold	45,476	–	–	﹤0.01%	349
2023 Q1	$4.65K	Hold	45,476	–	–	﹤0.01%	427
2022 Q4	$2.37K	Hold	45,476	–	–	﹤0.01%	621
2022 Q3	$3K	Hold	45,476	–	–	﹤0.01%	794
2022 Q2	$11K	Hold	45,476	–	–	﹤0.01%	641
2022 Q1	$10K	Hold	45,476	–	–	﹤0.01%	816
2021 Q4	$23K	Buy	+45,476	New	+$22.4K	﹤0.01%	709

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Whitebox Advisors's ESLAW Position: Q1 2026 in Review

Whitebox Advisors held its Estrella Immunopharma Warrant (ESLAW) position steady in Q1 2026 at 42,293 shares worth $3.17K. The position accounts for ﹤0.01% of the portfolio, ranked #551.

Whitebox Advisors first reported a position in ESLAW in Q4 2021 and has held it in 17 quarters since. The position peaked at $23K in Q4 2021. 8 funds tracked by Wall St. Rank hold ESLAW as of Q1 2026.

Whitebox Advisors held 42,293 shares of Estrella Immunopharma Warrant worth $3.17K as of Q1 2026.
Whitebox Advisors left its Estrella Immunopharma Warrant share count unchanged in Q1 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of Whitebox Advisors's portfolio in Q1 2026, its #551 holding.
Whitebox Advisors first reported a position in Estrella Immunopharma Warrant in Q4 2021 and has held it in 17 quarters since.
Whitebox Advisors's Estrella Immunopharma Warrant position peaked at $23K in Q4 2021.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q1 2026.

Based on Whitebox Advisors's 13F filing for Q1 2026, filed 15 May 2026.